Calamos Advisors’s BioLife Solutions BLFS Stock Holding History

Calamos Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-24,852	Closed	-$568K	–	927
2025 Q1	$568K	Sell	24,852 -8,169	-25%	-$215K	﹤0.01%	707
2024 Q4	$857K	Sell	33,021 -70,827	-68%	-$1.76M	﹤0.01%	686
2024 Q3	$2.6M	Buy	103,848 +46,598	+81%	+$1.1M	0.01%	585
2024 Q2	$1.23M	Buy	+57,250	New	+$1.11M	0.01%	629
2022 Q1	–	Sell	-61,337	Closed	-$2.29M	–	1168
2021 Q4	$2.29M	Buy	61,337 +24,558	+67%	+$1.05M	0.01%	879
2021 Q3	$1.56M	Buy	36,779 +1,330	+4%	+$64K	0.01%	806
2021 Q2	$1.58M	Sell	35,449 -20,314	-36%	-$716K	0.01%	756
2021 Q1	$2.01M	Sell	55,763 -46,880	-46%	-$1.85M	0.01%	691
2020 Q4	$4.09M	Sell	102,643 -3,375	-3%	-$115K	0.02%	527
2020 Q3	$3.07M	Buy	+106,018	New	+$2.29M	0.02%	533

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Calamos Advisors's BLFS Position: Q2 2025 in Review

Calamos Advisors sold out of BioLife Solutions (BLFS) in Q2 2025, closing a stake of 24,852 shares — an estimated $568K sold.

Calamos Advisors first reported a position in BLFS in Q3 2020 and held it in 10 quarters. The position peaked at $4.09M in Q4 2020. 194 funds tracked by Wall St. Rank hold BLFS as of Q2 2025.

Calamos Advisors reported no remaining BioLife Solutions position as of Q2 2025 after selling out during the quarter.
Calamos Advisors sold 24,852 BioLife Solutions shares in Q2 2025, an estimated $568K.
Calamos Advisors first reported a position in BioLife Solutions in Q3 2020 and held it in 10 quarters.
Calamos Advisors's BioLife Solutions position peaked at $4.09M in Q4 2020.
194 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2025.

Based on Calamos Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.